Clinical trials
Terminated Phase 1 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 4 |
| 2015 | 2 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| GlaxoSmithKline | 2 |
| Takeda | 2 |
| Amgen | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Johns Hopkins University | 1 |
| Maria de las Mercedes Perez Rodriguez | 1 |
| Monash University | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Neurocrine Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 20 |
| Psychotic Disorders | 4 |
| Bipolar Disorder | 3 |
| Cognition Disorders | 2 |
| Alzheimer Disease | 1 |
| Autism Spectrum Disorder | 1 |
| Borderline Personality Disorder | 1 |
| Cerebellar Ataxia | 1 |
| Major Depressive Disorder | 1 |
| Mental Disorders | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.